UK Healthcare Regulator Backs Stronger AI Oversight, Not Overhaul
The UK's National Commission into the Regulation of AI in Healthcare has found strong public support for reforming how artificial intelligence is governed in clinical settings, based on feedback from more than 770 respondents to a recent call for evidence.
The commission's preliminary findings show broad agreement that existing regulatory frameworks should be strengthened rather than replaced entirely. The focus centers on improving post-market surveillance and continuous monitoring of AI systems after they are deployed in hospitals and clinics.
Henrietta Hughes, patient safety commissioner and deputy chair of the commission, said the responses demonstrate public appetite for change within the current system. "There is strong support for reform of the current regulatory approach," Hughes said. "People want meaningful change, but not a complete overhaul. This reflects confidence in parts of the existing system, alongside a need to strengthen and adapt it as technologies evolve."
Accountability Gaps Emerge as Key Concern
Respondents flagged accountability and oversight as priority issues. They want clearer answers on how AI-powered medical devices are monitored once in use and how responsibility is assigned when problems occur.
Trust in AI healthcare systems depends on both the technology itself and the regulatory frameworks governing it. The commission is continuing consultations with patients, clinicians, and industry stakeholders through public engagement sessions and roundtables led by the Medicines and Healthcare products Regulatory Agency (MHRA).
For healthcare professionals working with AI systems, understanding these regulatory developments matters. The commission's direction will likely shape how you implement and oversee AI tools in your organization. Learn more about AI for Healthcare and how regulatory frameworks apply to your work.
Your membership also unlocks:
